Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Option Activity (Details)

v3.22.1
Schedule of Stock Option Activity (Details)
 3 Months Ended
Mar. 31, 2022
$ / shares
shares
Option Indexed to Issuer's Equity [Line Items]  
Number of Options, Beginning balance | shares 175,384
Weighted Average Exercise Price, Beginning balance | $ / shares $ 1.78
Weighted Average Remaining Contractual Term (years), Vested and Exercisable, Outstanding balance 3 years 3 months 18 days
Number of Options, Options granted | shares 522,462
Weighted Average Exercise Price, Options granted | $ / shares $ 1.26
Weighted Average Remaining Contractual Term (years), Options granted 7 years 9 months 18 days
Number of Options, Ending balance | shares 697,846
Weighted Average Exercise Price, Ending balance | $ / shares $ 1.39
Share-Based Payment Arrangement, Option [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Weighted Average Remaining Contractual Term (years), Outstanding balance 6 years 7 months 6 days
Number of Options, Exercisable, Ending balance | shares 301,335
Weighted Average Exercise Price, Exercisable, Ending balance | $ / shares $ 1.56
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 5 years 1 month 6 days